For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, IGM Biosciences Inc (NASDAQ: IGMS) closed at $6.40 down -1.69% from its previous closing price of $6.51. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 0.14 million shares were traded. IGMS stock price reached its highest trading level at $6.72 during the session, while it also had its lowest trading level at $6.1291.
Ratios:
For a deeper understanding of IGM Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.22 and its Current Ratio is at 5.22. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on December 06, 2024, initiated with a Outperform rating and assigned the stock a target price of $21.
On October 01, 2024, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $24 to $12.
JP Morgan Downgraded its Neutral to Underweight on October 01, 2024, whereas the target price for the stock was revised from $12 to $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 16 ’24 when Weber Steven sold 539 shares for $7.48 per share. The transaction valued at 4,032 led to the insider holds 31,704 shares of the business.
Decker Lisa Lynn sold 1,063 shares of IGMS for $7,951 on Dec 16 ’24. The CHIEF BUSINESS OFFICER now owns 78,041 shares after completing the transaction at $7.48 per share. On Dec 16 ’24, another insider, Harler Mary Beth, who serves as the Chief Executive Officer of the company, sold 1,708 shares for $7.48 each. As a result, the insider received 12,776 and left with 347,032 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGMS now has a Market Capitalization of 380570880 and an Enterprise Value of 237372848. For the stock, the TTM Price-to-Sale (P/S) ratio is 130.33 while its Price-to-Book (P/B) ratio in mrq is 4.82. Its current Enterprise Value per Revenue stands at 81.348 whereas that against EBITDA is -1.06.
Stock Price History:
Over the past 52 weeks, IGMS has reached a high of $22.50, while it has fallen to a 52-week low of $6.15. The 50-Day Moving Average of the stock is -45.62%, while the 200-Day Moving Average is calculated to be -39.14%.
Shares Statistics:
For the past three months, IGMS has traded an average of 267.75K shares per day and 248130 over the past ten days. A total of 34.06M shares are outstanding, with a floating share count of 17.60M. Insiders hold about 70.41% of the company’s shares, while institutions hold 30.82% stake in the company. Shares short for IGMS as of 1732838400 were 2703497 with a Short Ratio of 10.10, compared to 1730332800 on 3367234. Therefore, it implies a Short% of Shares Outstanding of 2703497 and a Short% of Float of 17.77.
